98%
921
2 minutes
20
The precise authentication of death from mechanical asphyxia (DMA) has been a complex problem in forensic medicine. Besides the traditional methods that concern the superficial characterization of the body, researchers are now paying more attention to the biomarkers that may help the identification of DMA. It has been reported that the extremely hypoxic environment created by DMA can cause the specific expression of mitochondria-related protein, which may sever as the biomarkers of DMA authentication. Since endoplasmic reticulum stress (ER stress) has been found to be related to the dysfunction of mitochondria, it is promising to look for the biomarkers of DMA among ER stress-related proteins. In this article, animal and cell experiments were conducted to examine how ER-mitochondria interaction may be influenced in the hypoxic condition caused by DMA primarily. Human samples were then used to verify the possible biomarkers of DMA. We found that ER stress-related protein CHOP was significantly up-regulated within a short-term postmortem interval (PMI) in brain tissue of DMA samples, which may interact with a series of ER stress- and mitochondria-related protein, leading to the apoptosis of the cells. It was also verified in human samples that the expression level of CHOP can sever as a potential biomarker of DMA within a specific PMI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00414-021-02770-1 | DOI Listing |
Nat Commun
August 2025
Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, BN1 9RQ, UK.
The Greatwall kinase inhibits PP2A-B55 phosphatase activity during mitosis to stabilise critical Cdk1-driven mitotic phosphorylation. Although Greatwall represents a potential oncogene and prospective therapeutic target, our understanding of the cellular and molecular consequences of chemical Greatwall inactivation remains limited. To address this, we introduce C-604, a highly selective Greatwall inhibitor, and characterise both immediate and long-term cellular responses to the chemical attenuation of Greatwall activity.
View Article and Find Full Text PDFJ Chem Phys
August 2025
School of Chemistry and Chemical Engineering, University of Southampton, University Road, Highfield, Southampton SO17 1BJ, United Kingdom.
Trimethylamine (TMA) is a tertiary aliphatic amine that stands as a potential marker for life beyond Earth due to only being naturally produced via biotic means. However, its propensity to undergo photodissociation in the gas phase when excited by a deep ultraviolet photon means that its amine daughter product could serve as an additional biomarker and confirmational spectral signature of TMA in exoplanetary atmospheres. The photochemistry of TMA is dominated by strong Rydberg-valence state interactions.
View Article and Find Full Text PDFJ Hazard Mater
September 2025
School of Public Health, Nanjing Medical University, Nanjing 210094, People's Republic of China; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, People's Republic of China. Electronic address:
Background: Emerging plasticizers are increasingly detected in environmental and human biological samples, yet data regarding human exposure and associated health risks remain limited.
Objectives: This study uniquely assesses human exposure to emerging plasticizers by simultaneously quantifying 26 metabolites and 8 serum lipid biomarkers. It aims to explore their associations with lipid metabolism, providing new insights into the potential metabolic disruptions caused by these compounds.
Biomedicines
July 2025
Laboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
B-cell precursor acute lymphoblastic leukemia (B-ALL) is characterized by a constellation of somatic pathogenic variants associated with malignant transformation. These variants have implications for clinical management by providing clinical biomarkers. Most B-ALL cases have a sporadic presentation.
View Article and Find Full Text PDFBMC Urol
July 2025
Dept. of Oncology, Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark.
Background: This clinical trial investigates the addition of a repurposed drug, the cationic amphiphilic drug (CAD) ebastine, to docetaxel in metastatic castration resistant prostate cancer (mCRPC). Preclinical data have shown that chemotherapy-resistant prostate cancer cells can be re-sensitized and that combining CAD with docetaxel significantly inhibits tumor growth in xenograft mouse models of docetaxel-resistant mCRPC. The primary objective of this study is to evaluate the impact of ebastine plus docetaxel versus docetaxel alone for mCRPC, measured as Bis(monoacylglycero)phosphate (BMP) and lysophospholipids in urine and blood.
View Article and Find Full Text PDF